Western Europe Australia North America South America Eastern Europe Middle East Central America Asia Africa
home covid test in Norway.FDA EUA CE ISO GMP SFC ETC
Product Description
The BinaxNOW COVID-19 Antigen Self Test has not been FDA cleared or approved. home covid test in Norway It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARSCoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act,  home covid test in Norway 21 U.S.C. 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. BinaxNOW COVID-19 Antigen Self Test should be performed twice in 3 days, at least 36 hours apart